Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Neoforce Group, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

106 daysmedian FDA review time
143 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K110119PRESSURE MANOMETERNeoforce Group, Inc.2011-06-101430
K103833NEOPIP PATIENT CIRCUIT WITH PEEPNeoforce Group, Inc.2011-04-201110
K102649NEOPOP INFANT RESUSCITATOR WITH FLOW METERNeoforce Group, Inc.2011-01-061140
K092085ISPIRA RESUSCITATION UNITNeoforce Group, Inc.2009-10-07900
K072021NEOPIP INFANT RESUSCITATORNeoforce Group, Inc.2007-09-12510
K070416NEOPEEP NEONATAL RESUSCITATION CIRCUIT WITH PEEPNeoforce Group, Inc.2007-05-291060
K061280V-2200 INFANT INCUBATORNeoforce Group, Inc.2006-06-27500

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda